LOAMU
HALO icon

Lombard Odier Asset Management (USA)’s Halozyme HALO Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-200,000
Closed -$1.98M – 225
2016
Q4 		$1.98M Buy
+200,000
New +$2.19M 0.25% 112

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s HALO Position: Q4 2016 in Review

Lombard Odier Asset Management (USA) sold out of Halozyme (HALO) in Q4 2016, closing a stake of 350,904 shares — an estimated $3.84M sold.

Lombard Odier Asset Management (USA) first reported a position in HALO in Q2 2014 and held it in 10 quarters. The position peaked at $38.3M in Q2 2015. 168 funds tracked by Wall St. Rank hold HALO as of Q4 2016.

  • Lombard Odier Asset Management (USA) reported no remaining Halozyme position as of Q4 2016 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 350,904 Halozyme shares in Q4 2016, an estimated $3.84M.
  • Lombard Odier Asset Management (USA) first reported a position in Halozyme in Q2 2014 and held it in 10 quarters.
  • Lombard Odier Asset Management (USA)'s Halozyme position peaked at $38.3M in Q2 2015.
  • 168 funds tracked by Wall St. Rank held Halozyme as of Q4 2016.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2016, filed 15 Feb 2017.